TUBG1 and cancer: In addition, the use of γ-tubulin to predict BRCA status showed sensitivity of 83% and specificity of 89% (Watanabe et al., 2018), suggesting that TUBG1 is a promising diagnostic biomarker for HCC and has potential value for diagnosing other cancers.